This study is a prospective, observational clinical research aimed at establishing a multimodal database encompassing clinical information and gut microbiome data from a sample of over 1,000 breast cancer patients comorbid with depression. The research involves collecting cohort sample information from breast cancer patients with comorbid depression, as well as fecal, blood, and saliva specimens for metagenomic sequencing, untargeted metabolite detection, and cortisol level analysis, respectively. Based on the collected multimodal data, diagnostic, efficacy prediction, and prognostic survival prediction models for breast cancer with comorbid depression will be developed. Additionally, a precision prediction cloud platform will be designed and deployed to support data upload, model prediction, and result visualization.
Study Type
OBSERVATIONAL
Enrollment
1,000
Xiangya Hospital of Central South University
Changsha, Hunan, China
RECRUITINGobjective response rate,ORR
The propotion defined as subjects with complete remission (CR) and partial remission (PR) among all subjects.
Time frame: 2025-03-11 to 2027-03-01
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.